Stay updated with breaking news from Api Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It said that the RBI should set up an RE-agnostic common portal for lodging complaints so that the customers of any RE can lodge complaints on a single platform.
CMP: ₹2,153.75 From our interaction with the management, we believe Ipca Laboratories (IPCA) has enough levers to outperform the market in Domestic Formulations (DF) and Branded Generics exports, with good visibility in the Institutional business and continued momentum in the API segment. IPCA has witnessed sustained growth momentum in the Pain segment. It has posted market share gains, on account of the pandemic, in products wherein smaller companies have been unable to meet supply requirements. Moreover, higher prescriptions for established brands such as Zerodol have enhanced growth pro...